A rapid ABO and RhD test demonstrates high fidelity to blood bank testing for RhD typing

Abstract

AbstractBackgroundThe rapid provision of blood products is life‐saving for patients with massive hemorrhage. Ideally, RhD‐negative blood products would be supplied to a woman of childbearing potential whose Rh type is unknown due to the risk of D‐alloimmunization and the potential for hemolytic disease of the fetus and newborn to occur if RhD‐positive blood products are transfused. Therefore, there is a need for a test that rapidly determines her RhD type. This study compared the RhD type determined using a rapid ABO and RhD test to the RhD type determined by an immunohematology reference laboratory.MethodsAfter receiving ethics review board approval, 200 random, unique, deidentified patient samples that had undergone routine pretransfusion testing in an immunohematology reference laboratory using column agglutination technology were collected and tested using a rapid ABO and RhD test (Eldoncard Home kit 2511). The RhD typing results from these two methods were compared to determine the accuracy of the rapid ABO and RhD test.ResultsThe rapid ABO and RhD test produced results that were concordant with the transfusion service's results in 199/200 (99.5%) of cases, with a negative predictive value of 98.2% and 99.3% sensitivity. The single outlier was likely an RhD variant due to its serological characteristics.DiscussionThese data indicate that this rapid ABO and RhD test could be used for the rapid determination of a patient's RhD type, perhaps even in the emergency department, which could guide the selection of blood products provided during their resuscitation.